NYSE:CAH - Cardinal Health Stock Price, Price Target & More

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health declared a quarterly dividend on Wednesday, May 9th. Shareholders of record on Monday, July 2nd will be paid a dividend of $0.476 per share on Sunday, July 15th. This represents a $1.90 dividend on an annualized basis and a dividend yield of 3.81%. The ex-dividend date is Friday, June 29th. This is an increase from Cardinal Health's previous quarterly dividend of $0.46. View Cardinal Health's Dividend History.

Cardinal Health announced that its Board of Directors has initiated a stock repurchase plan on Thursday, February 8th 2018, which allows the company to repurchase $1,000,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to reacquire shares of its stock through open market purchases. Shares repurchase plans are often an indication that the company's management believes its shares are undervalued.

Cardinal Health Inc (NYSE:CAH) released its quarterly earnings results on Thursday, May, 3rd. The company reported $1.39 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $1.51 by $0.12. The business had revenue of $33.63 billion for the quarter, compared to the consensus estimate of $33.61 billion. Cardinal Health had a return on equity of 23.39% and a net margin of 1.26%. View Cardinal Health's Earnings History.

Cardinal Health is scheduled to release their next quarterly earnings announcement on Tuesday, July, 31st 2018. View Earnings Estimates for Cardinal Health.

Cardinal Health updated its FY18 earnings guidance on Thursday, May, 3rd. The company provided EPS guidance of $4.85-4.95 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.42.

15 analysts have issued 1-year target prices for Cardinal Health's shares. Their predictions range from $40.00 to $81.00. On average, they anticipate Cardinal Health's share price to reach $66.9286 in the next year. This suggests a possible upside of 33.9% from the stock's current price. View Analyst Ratings for Cardinal Health.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 2 sell ratings, 9 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), PetIQ (PETQ), Aceto (ACET), biOasis Technologies (BIOAF), Trxade Group (TRXD) and Medizone International (MZEI).

Press coverage about CAH stock has trended somewhat negative recently, Accern Sentiment reports. The research firm rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Cardinal Health earned a media sentiment score of -0.02 on Accern's scale. They also assigned media coverage about the company an impact score of 45.24 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Cardinal Health's stock is owned by a number of of retail and institutional investors. Top institutional investors include Hexavest Inc. (0.30%), Deprince Race & Zollo Inc. (0.14%), Bank of Montreal Can (0.09%), Howard Capital Management Inc. (0.07%), Retirement Systems of Alabama (0.05%) and Denali Advisors LLC (0.04%). Company insiders that own Cardinal Health stock include Craig S Morford, Donald M Jr Casey, George S Barrett, Jon L Giacomin, Michael C Kaufmann, Patricia Morrison and Stuart G Laws. View Institutional Ownership Trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hexavest Inc., Retirement Systems of Alabama, Riverbridge Partners LLC, Trust Co. of Toledo NA OH, Welch & Forbes LLC and Gateway Investment Advisers LLC. Company insiders that have sold Cardinal Health company stock in the last year include Jon L Giacomin, Michael C Kaufmann and Patricia Morrison. View Insider Buying and Selling for Cardinal Health.

CAH stock was acquired by a variety of institutional investors in the last quarter, including Capital Investment Advisors LLC, Howard Capital Management Inc., Deprince Race & Zollo Inc., State of Alaska Department of Revenue, Regent Investment Management LLC, Kempner Capital Management Inc., Denali Advisors LLC and DnB Asset Management AS. View Insider Buying and Selling for Cardinal Health.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $49.97.

Cardinal Health has a market capitalization of $15.75 billion and generates $129.98 billion in revenue each year. The company earns $1.29 billion in net income (profit) each year or $5.40 on an earnings per share basis. Cardinal Health employs 28,000 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]